Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes

by Blonde, Lawrence, Pencek, Richard, MacConell, Leigh
Published 2015

Randomized Comparison of Pramlintide or Mealtime Insulin Added to Basal Insulin Treatment for Patients With Type 2 Diabetes

by Riddle, Matthew, Pencek, Richard, Charenkavanich, Supoat, Lutz, Karen, Wilhelm, Ken, Porter, Lisa
Published 2009

Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years

by Taylor, Kristin, Gurney, Kate, Han, Jenny, Pencek, Richard, Walsh, Brandon, Trautmann, Michael
Published 2011

Exenatide once weekly: sustained improvement in glycemic control and cardiometabolic measures through 3 years

by MacConell, Leigh, Pencek, Richard, Li, Yan, Maggs, David, Porter, Lisa
Published 2013

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis

by Gaebler, Julia A, Soto-Campos, Gerardo, Alperin, Peter, Cohen, Marc, Blickensderfer, Amy, Wintle, Matthew, Maggs, David, Hoogwerf, Byron, Han, Jenny, Pencek, Richard, Peskin, Barbara
Published 2012